We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Omega Healthcare Investors (OHI) Stock Moves -0.43%: What You Should Know
Read MoreHide Full Article
Omega Healthcare Investors (OHI - Free Report) closed the most recent trading day at $30.27, moving -0.43% from the previous trading session. This change was narrower than the S&P 500's 2.37% loss on the day. Elsewhere, the Dow lost 1.35%, while the tech-heavy Nasdaq lost 0.24%.
Heading into today, shares of the health care real estate investment trust had lost 0.13% over the past month, outpacing the Finance sector's loss of 6.57% and the S&P 500's loss of 6.51% in that time.
Wall Street will be looking for positivity from Omega Healthcare Investors as it approaches its next earnings report date. In that report, analysts expect Omega Healthcare Investors to post earnings of $0.77 per share. This would mark a year-over-year decline of 9.41%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $249.8 million, down 11.31% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $3.04 per share and revenue of $993.81 million, which would represent changes of -8.16% and -6.49%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Omega Healthcare Investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Omega Healthcare Investors is currently sporting a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Omega Healthcare Investors has a Forward P/E ratio of 10 right now. This represents a discount compared to its industry's average Forward P/E of 11.44.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 125, putting it in the top 50% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Omega Healthcare Investors (OHI) Stock Moves -0.43%: What You Should Know
Omega Healthcare Investors (OHI - Free Report) closed the most recent trading day at $30.27, moving -0.43% from the previous trading session. This change was narrower than the S&P 500's 2.37% loss on the day. Elsewhere, the Dow lost 1.35%, while the tech-heavy Nasdaq lost 0.24%.
Heading into today, shares of the health care real estate investment trust had lost 0.13% over the past month, outpacing the Finance sector's loss of 6.57% and the S&P 500's loss of 6.51% in that time.
Wall Street will be looking for positivity from Omega Healthcare Investors as it approaches its next earnings report date. In that report, analysts expect Omega Healthcare Investors to post earnings of $0.77 per share. This would mark a year-over-year decline of 9.41%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $249.8 million, down 11.31% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $3.04 per share and revenue of $993.81 million, which would represent changes of -8.16% and -6.49%, respectively, from the prior year.
Investors might also notice recent changes to analyst estimates for Omega Healthcare Investors. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Omega Healthcare Investors is currently sporting a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Omega Healthcare Investors has a Forward P/E ratio of 10 right now. This represents a discount compared to its industry's average Forward P/E of 11.44.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 125, putting it in the top 50% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.